Evidence map›Paper›PMID 36295489›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction.

Shan Wu, Jing Xu, Guang Li, Xi Jin

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Heterogeneity in precision oncology.Cambridge prisms. Precision medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shan WuDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang 110001, China.
Jing XuDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang 110001, China.
Guang LiDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang 110001, China.
Xi JinKey Laboratory of Networked Control Systems, Chinese Academy of Sciences, Shenyang 110016, China.ORCID 0000-0002-1839-2714

Funding

Youth Innovation Promotion Association of the Chinese Academy of Sciences 2021062
6 · The paper itself

Abstract

Response to radiotherapy (RT) in gliomas varies widely between patients. It is necessary to identify glioma-associated radiosensitivity gene signatures for clinically stratifying patients who will benefit from adjuvant radiotherapy after glioma surgery.

Indexed as

GliomaHumansRadiation ToleranceRegression AnalysisROC Curvegene signaturesgliomaradiosensitivity

Identifiers

PMID36295489
PMCPMC9609360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.